Prostate cancer: WHO standardization of PSA tests: clinical consequences.
The introduction of WHO standards for PSA assays is a step forward for improving the comparability of these tests. our current clinical decision limits, however, were validated using traditional calibrators. The threshold for biopsy must be adjusted when using the new standards.
Stephan
Carsten
C
D014408:Biomarkers, Tumor / Q000097:blood / Q000592:standards*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood / Q000592:standards*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D012015:Reference Standards; D014944:World Health Organization
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen